van der Wulp, Willemijn http://orcid.org/0000-0002-0364-1300
Remst, Dennis F. G.
Kester, Michel G. D.
Hagedoorn, Renate S.
Parren, Paul W. H. I. http://orcid.org/0000-0002-4365-3859
van Kasteren, Sander I.
Schuurman, Janine http://orcid.org/0000-0002-9738-9926
Hoeben, Rob C. http://orcid.org/0000-0001-9443-8377
Ressing, Maaike E.
Bleijlevens, Boris
Heemskerk, Mirjam H. M. http://orcid.org/0000-0001-6320-9133
Funding for this research was provided by:
This work was performed under a grant provided by Genmab.
Article History
Received: 25 July 2023
Revised: 29 September 2023
Accepted: 17 October 2023
First Online: 9 November 2023
Competing interests
: BB, PWHIP, and JS are (former) employees at Genmab BV and have ownership interests (including stocks, warrants, patents, etc.).
: Healthy donor material from the Leiden University Medical Center Biobank for Hematological Diseases was used in this study. This research was approved by the Institutional Review Board of the Leiden University Medical Center (approval number B16.039). Materials were obtained after written informed consent in accordance with the Declaration of Helsinki.